Literature DB >> 1933932

Interactions of five D-mannose-specific lectins with a series of synthetic branched trisaccharides.

H Kaku1, I J Goldstein, S Oscarson.   

Abstract

The interaction of a series of synthetic, branched trisaccharides with five D-mannose-specific lectins was studied by precipitation-inhibition assay. The branched methyl alpha-D-mannotrioside, alpha-D-Manp-(1----3)-[alpha-D-Manp-(1----6)]-alpha-D-Man pOMe, the best inhibitor of the Con A-Dextran interaction, was 42 times more potent than alpha-D-ManpOMe, and 3-6 times more potent than the two trisaccharides substituted with D-glucosyl groups, and 8-15 times those with D-galactosyl groups. Surprisingly, methyl O-alpha-D-mannopyranosyl-(1----3)-alpha-D-mannopyranoside was bound to Con A 8-fold more avidly than methyl alpha-D-mannopyranoside. However, the related pea lectin (PSA) was singularly different from Con A in its carbohydrate-binding activity, showing no significantly enhanced binding to any of the sugars examined. The trisacchrides containing terminal, nonreducing, (1----3)-linked alpha-D-mannopyranosyl groups, i.e., alpha-D-Manp-(1----3)-[alpha-D-Glep-(1----6)]alpha-D-Manp OMe, alpha-D-Manp-(1----3)]-alpha-D-Galp-(1----6)]-alpha-D-ManpOMe++ +, and alpha-D-Manp-(1----3)-[alpha-D-Manp-(1----6)]-alpha-D-Man pOMe, were the best inhibitors of the snowdrop lectin (GNA)-D-mannan precipitation system. On the other hand, all branched trisaccharides exhibited very similar inhibitory potencies toward the daffodil lectin (NPA)-D-mannan interaction, whereas alpha-D-Manp-(1----3)-[alpha-D-Galp-(1----6)]-alpha-D-ManpOMe++ + and alpha-D-Manp-(1----3)-[alpha-D-Manp-(1----6)]-alpha-D-Man pOMe were somewhat better inhibitors than the other branched trisaccharides of the amaryllis lectin (HHA)-D-mannan precipitation reaction. (ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1933932     DOI: 10.1016/s0008-6215(00)90602-5

Source DB:  PubMed          Journal:  Carbohydr Res        ISSN: 0008-6215            Impact factor:   2.104


  7 in total

1.  A new high molecular weight agglutinin from garlic (Allium sativum).

Authors:  A Gupta; R S Sandhu
Journal:  Mol Cell Biochem       Date:  1997-01       Impact factor: 3.396

2.  Optimizing lectin-carbohydrate interactions: improved binding of divalent alpha-mannosylated ligands towards Concanavalin A.

Authors:  D Pagé; R Roy
Journal:  Glycoconj J       Date:  1997-04       Impact factor: 2.916

3.  Overexpression of α (1,6) fucosyltransferase associated with aggressive prostate cancer.

Authors:  Xiangchun Wang; Jing Chen; Qing Kay Li; Sarah B Peskoe; Bai Zhang; Caitlin Choi; Elizabeth A Platz; Hui Zhang
Journal:  Glycobiology       Date:  2014-06-05       Impact factor: 4.313

4.  Isolation and preliminary characterization of the 14- to 18-kilodalton Candida albicans antigen as a phospholipomannan containing beta-1,2-linked oligomannosides.

Authors:  P A Trinel; M Borg-von-Zepelin; G Lepage; T Jouault; D Mackenzie; D Poulain
Journal:  Infect Immun       Date:  1993-10       Impact factor: 3.441

5.  Partial overlap of anti-mycobacterial, and anti-Saccharomyces cerevisiae mannan antibodies in Crohn's disease.

Authors:  Stefan Müller; Thomas Schaffer; Alain M Schoepfer; Annamarie Hilty; Thomas Bodmer; Frank Seibold
Journal:  World J Gastroenterol       Date:  2008-06-21       Impact factor: 5.742

6.  Structural basis for a human glycosylation disorder caused by mutation of the COG4 gene.

Authors:  Brian C Richardson; Richard D Smith; Daniel Ungar; Ayumi Nakamura; Philip D Jeffrey; Vladimir V Lupashin; Frederick M Hughson
Journal:  Proc Natl Acad Sci U S A       Date:  2009-07-27       Impact factor: 11.205

7.  O-GlcNAcylation mediates metastasis of cholangiocarcinoma through FOXO3 and MAN1A1.

Authors:  Chatchai Phoomak; Atit Silsirivanit; Dayoung Park; Kanlayanee Sawanyawisuth; Kulthida Vaeteewoottacharn; Chaisiri Wongkham; Eric W-F Lam; Chawalit Pairojkul; Carlito B Lebrilla; Sopit Wongkham
Journal:  Oncogene       Date:  2018-06-18       Impact factor: 9.867

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.